Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Immune Response After Administration of 2 vs. 3 Doses of the FDA-approved 9-Valent HPV Vaccine Among Women 27-45 Years of Age

NCT05672927 is registered in ClinicalTrials.gov with The University of Texas Medical Branch, Galveston as lead sponsor.

NCT NCT05672927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05672927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Immune Response After Administration of 2 vs. 3 Doses of the FDA-approved 9-Valent HPV Vaccine Among Women 27-45 Years of Age
Lead sponsor
The University of Texas Medical Branch, Galveston
Phase
Phase 4
Overall status
Recruiting
Start date
January 18, 2023
Completion date
August 31, 2028
Enrollment
618 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hpv infection, human papillomavirus, immunization